Clinical Guides
Asthma
A clinically focused guide to confirming, assessing and managing asthma across Indian primary, emergency and specialist care, including inhaler technique, ICS-containing treatment, acute attacks, children, pregnancy and biologic referral while preserving patient-specific clinical judgement.
MedNext Academy | 13 min read
Asthma
A clinically focused guide to confirming, assessing and managing asthma across Indian primary, emergency and specialist care, including inhaler technique, ICS-containing treatment, acute attacks, children, pregnancy and biologic referral while preserving patient-specific clinical judgement.
Summary
Asthma is a heterogeneous chronic respiratory disease characterised by variable symptoms and variable expiratory airflow limitation. Typical symptoms are wheeze, breathlessness, chest tightness and cough that change over time and intensity; normal examination between episodes does not exclude the diagnosis. The central safety principle is to confirm asthma objectively whenever feasible, document the evidence, and revisit the diagnosis when the pattern or treatment response is atypical. Spirometry with bronchodilator reversibility is preferred, but peak-flow variability, bronchial challenge or other locally available tests may be needed.
Control and future risk are separate. Few current symptoms do not remove the risks created by previous severe attacks, excessive reliever use, poor adherence, incorrect technique, smoking, low lung function or lack of inhaled corticosteroid exposure. Adults and adolescents should receive an ICS-containing regimen rather than short-acting beta2-agonist alone. Every encounter should check the diagnosis, inhaler technique, adherence, exposures, comorbidities and a written action plan before escalating medicine.
A severe attack is a time-critical emergency: assess airway, breathing, circulation, mental state, oxygenation and airflow; start protocol-based bronchodilator and corticosteroid treatment; and arrange monitored transfer when danger features or poor response are present. Children, pregnancy, occupational disease and suspected severe asthma require tailored pathways. This guide remains an educational draft has been reviewed by the MedNext Clinical Team.
How Common Is It?
Asthma affects people of every age and remains an important cause of avoidable symptoms, school or work absence, emergency attendance and death. The World Health Organization's April 2026 fact sheet reports an estimated 363 million people affected in 2023 and 442,000 deaths, with most asthma-related deaths occurring in low- and lower-middle-income countries where underdiagnosis and undertreatment remain important. Those global estimates describe burden; they should not be presented as a current Indian prevalence or an individual's probability. Definitions, age groups, sampling, air quality, smoking exposure and access to spirometry materially change measured prevalence.
In India, clinicians see both under-recognition and over-labelling. Episodic cough may be attributed to infection, pollution or allergy without documenting variable airflow, while a historical asthma label may persist despite an alternative diagnosis. Cost, travel, device availability, health literacy and the fragmented path between primary clinic, pharmacy, emergency department and respiratory specialist influence outcomes. Children may present with recurrent wheeze, but preschool viral wheeze does not automatically establish persistent asthma.
Burden is uneven. Urban pollution, indoor biomass exposure, tobacco smoke, occupational sensitizers and seasonal allergens may interact with individual susceptibility. Population numbers must not substitute for case confirmation. The useful clinical questions are whether the symptom pattern is compatible, whether objective variability is demonstrated, whether treatment includes anti-inflammatory protection, and whether preventable attack risks have been addressed.
Risk Factors
Risk factors for developing asthma include personal or family atopy, allergic rhinitis, eczema, sensitisation to aeroallergens, early-life respiratory influences, tobacco smoke, occupational sensitizers and some environmental exposures. Obesity may worsen symptoms and control, although breathlessness in obesity should not be assumed to be asthma. Air pollution and household biomass smoke are clinically relevant in India, but a temporal exposure history is more informative than a generic attribution. Ask about work tasks, symptom improvement away from work, new materials, fumes, flour, isocyanates, laboratory animals and cleaning agents; suspected occupational asthma deserves early specialist assessment before exposure or employment changes obscure the relationship.
Risk factors for poor outcomes differ from risk factors for onset. A previous intubation, intensive-care admission or severe exacerbation, one or more recent attacks, low lung function, frequent reliever collection, inadequate ICS exposure, incorrect technique, poor adherence, smoking, psychosocial difficulty and eosinophilic or allergic inflammation increase concern. Comorbid rhinitis, reflux, obstructive sleep apnoea, anxiety, depression and inducible laryngeal obstruction can worsen symptoms or complicate interpretation.
Medicines can precipitate problems. Non-selective beta-blockers may cause bronchospasm, and aspirin or other NSAIDs can trigger respiratory reactions in susceptible people. Do not label every exposure causal or stop essential treatment abruptly; document timing and seek an alternative when appropriate. In a child, consider prematurity, feeding-related symptoms, foreign body, congenital disease and growth. In pregnancy, uncontrolled asthma and attacks pose maternal and fetal risks, so fear-driven withdrawal of preventer therapy is unsafe.
Diagnosis
History
Elicit wheeze, breathlessness, chest tightness and cough, including onset, frequency, nocturnal or early-morning pattern, variability, triggers and symptom-free intervals. Ask about exercise, viral infections, allergens, weather, smoke, workplace exposures, medicines, previous emergency care and response to bronchodilator or corticosteroid. Record atopy, rhinitis, eczema, family history, smoking or vaping, biomass exposure and comorbidities. Persistent isolated cough, sputum, haemoptysis, weight loss, inspiratory noise, cardiac symptoms or onset late in life should widen the differential.
Examination
Measure respiratory rate, pulse, blood pressure, oxygen saturation and ability to speak when symptomatic. Expiratory wheeze may be present, but a quiet chest in severe distress is dangerous and a normal chest between episodes is common. Look for accessory-muscle use, cyanosis, altered consciousness, upper-airway noise, cardiac signs, clubbing and unilateral findings. Assess rhinitis, eczema, body mass index and growth in children.
Investigations
Demonstrate variable expiratory airflow limitation before long-term treatment when possible. Perform quality-assured spirometry with bronchodilator reversibility; if initially normal, repeat during symptoms or after withholding bronchodilator safely. Serial peak expiratory flow, bronchial challenge or response to an ICS-containing trial may contribute according to age and availability. Current guidelines uses an ordered objective-test pathway that includes blood eosinophils or FeNO and spirometry in people aged five and over, but thresholds and sequencing are jurisdiction-specific. Chest imaging, ECG, blood tests or allergy assessment answer selected alternatives or phenotype questions; they are not routine substitutes for objective airflow evidence.
Differential Diagnosis
Asthma's variable pattern must be distinguished from disorders that cause persistent obstruction, intermittent upper-airway noise, cough or breathlessness. Chronic obstructive pulmonary disease is more likely with substantial smoke or biomass exposure, later onset and persistent post-bronchodilator obstruction, although asthma and COPD features can coexist. Post-infectious cough, upper-airway cough syndrome, rhinitis, gastro-oesophageal reflux and eosinophilic bronchitis may cause cough without classic variable obstruction. Bronchiectasis is suggested by chronic purulent sputum, recurrent infection or haemoptysis; tuberculosis must be considered in India when cough is persistent, systemic symptoms or exposure are present, or imaging is abnormal.
Inducible laryngeal obstruction often causes inspiratory difficulty, throat tightness or stridor and may be exercise-related. Dysfunctional breathing, panic, anaemia, obesity and deconditioning can mimic or amplify asthma symptoms. Heart failure, arrhythmia and ischaemia become more relevant with older age, orthopnoea, oedema or cardiac risk. A focal wheeze, abrupt onset or unilateral examination raises foreign body or endobronchial obstruction.
In infants and children, recurrent viral wheeze, bronchiolitis, aspiration, congenital airway abnormality, cystic fibrosis, primary ciliary dyskinesia and foreign-body inhalation belong in the differential. Poor growth, clubbing, neonatal symptoms, continuous wheeze or failure to respond should trigger reassessment. The safe rule is to re-open the diagnosis when objective tests remain normal, escalation produces no clear benefit, or features cannot be explained by asthma rather than adding progressively intensive treatment to an uncertain label.
Management
Agree goals with the patient: minimal symptoms and activity limitation, low attack risk, preserved lung function and the least treatment burden that safely achieves these aims. Education covers the chronic inflammatory basis, trigger reduction without impractical blanket avoidance, smoking cessation, vaccination according to national schedules, physical activity, weight and comorbidity care. Provide a written action plan showing usual treatment, how to recognise deterioration, what temporary steps are authorised and when to seek urgent help. At every review, assess symptom control over the preceding weeks and independently review attacks, lung function, reliever use and modifiable risks. Asthma severity is assessed retrospectively by the treatment intensity required for control; it is not interchangeable with today's symptom score or the severity of one acute attack.
Use an ICS-containing strategy for adults and adolescents. GINA prefers an anti-inflammatory reliever track using low-dose ICS-formoterol where approved and available; an alternative track combines regular ICS-containing maintenance with an appropriate reliever. Exact step, device and dose depend on age, severity, formulary, availability and clinician assessment. Before stepping up, confirm asthma, demonstrate and observe technique, assess adherence and address exposures and comorbidities. Step down cautiously only after sustained control, with follow-up and continued ICS protection rather than abrupt cessation.
During an acute attack, grade severity repeatedly, give inhaled rapid bronchodilator by a suitable device, add ipratropium and systemic corticosteroid for severe attacks according to protocol, titrate oxygen rather than giving it indiscriminately, and transfer urgently for exhaustion, hypoxaemia, silent chest, altered consciousness or inadequate response. Difficult-to-treat asthma becomes severe asthma only after diagnosis, adherence, technique, exposure and comorbidity have been optimized; specialist phenotype assessment may then identify eligibility for biologics rather than empirical initiation in primary care.
Prescribing Information
Inhaled corticosteroids are the foundation of anti-inflammatory treatment. Select a locally available device that the patient can use correctly, prescribe by generic medicine and device when possible, and verify dose equivalence because low, medium and high categories are product- and age-specific. Demonstrate, observe and correct technique; a spacer improves delivery from a pressurised metered-dose inhaler and is particularly valuable during attacks and for many children. Advise mouth rinsing after ICS where appropriate, monitor dysphonia or candidiasis, and use the lowest effective dose once stable. Growth should be followed in children, while the harm of uncontrolled asthma must be weighed against small treatment effects.
ICS-formoterol can serve as maintenance-and-reliever therapy only with formulations and plans supported for that use. Other ICS-LABA products must not be assumed interchangeable as relievers. SABA-only treatment leaves airway inflammation untreated and frequent use signals risk. Leukotriene receptor antagonists have a limited role and require counselling about possible neuropsychiatric adverse effects. Long-acting muscarinic antagonists and biologics are add-on options after specialist evaluation. Repeated oral corticosteroid courses accumulate metabolic, bone, ocular, infectious and psychiatric harm.
For attacks, prescribe bronchodilator, ipratropium and systemic corticosteroid through a verified age- and severity-specific emergency protocol; avoid sedatives. Antibiotics are not routine unless bacterial infection is supported. In pregnancy, continue effective ICS-containing therapy and treat exacerbations promptly; do not reduce treatment solely because of pregnancy. Check interactions, comorbidity and supply. This section supports safe verification and is not a patient-specific dose instruction.
When to Refer
Refer urgently or transfer to emergency care for severe respiratory distress, inability to speak normally, exhaustion, cyanosis, altered consciousness, silent chest, marked hypoxaemia, rapidly worsening peak flow, poor response to initial bronchodilator treatment, or any concern that safe monitoring cannot be provided. A person who recovers from a significant attack still needs early follow-up to review the cause, inhaler technique, adherence, controller treatment and action plan. Previous intensive-care asthma lowers the threshold for emergency assessment and specialist involvement.
Refer to respiratory or allergy services when the diagnosis remains uncertain after appropriate objective testing; symptoms and test results conflict; occupational asthma is possible; an alternative structural or systemic diagnosis is suspected; or asthma remains uncontrolled despite optimized treatment. Specialist assessment is required before biologic therapy and is appropriate for repeated systemic steroid courses, recurrent admissions, persistent airflow limitation, significant treatment adverse effects, or suspected aspirin-exacerbated respiratory disease. Consider ENT, gastroenterology, cardiology, speech therapy or mental-health input when a comorbidity is driving symptoms.
Children with diagnostic uncertainty, poor growth, neonatal-onset or continuous symptoms, focal signs, repeated hospital care or poor treatment response need paediatric assessment. Pregnancy with poor control or an exacerbation requires coordinated obstetric and respiratory care. In India, specify the actual receiving facility and urgency; district hospitals, medical colleges and private respiratory services differ in spirometry, FeNO, allergy testing, intensive care and biologic access. Referral is a transfer of responsibility only when communication and follow-up are confirmed.
Red Flags
Red flags during an attack include drowsiness, confusion, agitation, exhaustion, cyanosis, inability to complete sentences, a silent or poorly moving chest, bradycardia, hypotension, marked hypoxaemia, worsening hypercapnia or rapidly declining airflow. Apparent reduction in wheeze is not reassuring if air entry and effort deteriorate. Peak flow supports assessment when it can be performed safely but must not delay treatment or transfer. A history of near-fatal asthma, recent hospitalization, repeated emergency attendance, excess reliever use or lack of ICS increases concern even before dramatic examination findings appear.
Red flags against uncomplicated asthma include haemoptysis, persistent fever, weight loss, clubbing, fixed unilateral wheeze, focal crepitations, stridor, dysphagia, recurrent pneumonia, abnormal cardiac findings and persistent oxygen desaturation between episodes. In India, prolonged cough with systemic or radiographic features should prompt tuberculosis evaluation through the appropriate pathway. Sudden pleuritic pain and breathlessness may indicate pneumothorax or pulmonary embolism. Anaphylaxis with wheeze requires intramuscular adrenaline and anaphylaxis management rather than treating bronchospasm alone.
In children, apnoea, cyanosis, poor feeding, reduced responsiveness, a suspected inhaled foreign body or severe recession requires urgent assessment. In pregnancy, maternal hypoxaemia threatens both mother and fetus and must be corrected promptly. Social inability to obtain medication, understand the action plan or reach emergency care is a clinical safety issue. Discharge is unsafe without stable improvement, clear medicine instructions, inhaler competence, return precautions and timely review.
Indian Clinical Context
Asthma care in India spans health and wellness centres, general practices, pharmacies, district hospitals, medical colleges and specialist services. Objective confirmation can be limited by absent or poorly maintained spirometry, lack of trained operators, travel and out-of-pocket costs. That limitation should be documented, not converted into false certainty. When spirometry is unavailable, a structured symptom history and serial peak-flow record may strengthen assessment, but referral for quality-assured testing remains important when the diagnosis is doubtful, symptoms are severe or long-term escalation is contemplated.
Affordability and supply shape adherence. Ask which inhalers the patient can obtain consistently, inspect the exact device, and avoid switching devices without retraining. Generic prescriptions still require device specificity because technique differs. Shared inhalers and nebulizers create infection-control and dosing problems; a pressurised inhaler with spacer is effective for many attacks when the patient can use it and severity allows. Biomass smoke, tobacco, outdoor pollution and occupational exposure should be explored without blaming families who cannot immediately alter housing or employment.
Public education must counter the belief that controller inhalers are addictive or that they should be reserved until severe symptoms occur. It must also avoid promising a cure. A written action plan should be understandable in the person's preferred language and fit available emergency transport. Tuberculosis and post-tuberculous lung disease remain relevant alternative or coexisting diagnoses. FeNO, bronchial challenge and biologics may be concentrated in tertiary centres; referral decisions should acknowledge access and cost while preserving evidence-based ICS-containing care at primary level.
NMC Competency Mapping
Within undergraduate medicine, asthma teaching integrates respiratory symptom assessment, examination, interpretation of spirometry or peak flow, differential diagnosis, pharmacology, emergency recognition and long-term communication. Relevant NMC curriculum themes include evaluating cough, breathlessness and wheeze; identifying obstructive airway disease; demonstrating respiratory examination; interpreting pulmonary function tests; and describing pharmacological and non-pharmacological treatment. Exact competency codes should be checked against the institution's current CBME implementation rather than inferred from a secondary mapping.
A learner should be able to take an exposure-sensitive history, recognise symptom variability, distinguish control from future attack risk and explain why objective confirmation matters. Practical competence includes measuring vital signs, assessing severity, demonstrating an inhaler and spacer, observing patient technique, constructing a safe differential and escalating an attack. Interpretation should cover obstructive spirometry, bronchodilator change, limitations of a normal test and the role of serial peak flow without treating any single threshold as infallible.
Therapeutic learning should connect inhaled corticosteroid action with the rejection of SABA-only care, while distinguishing controller, reliever and add-on roles. Students should know that severe asthma is diagnosed only after adherence, technique, exposure and comorbidity have been addressed. Communication competencies include a written action plan, pregnancy reassurance, smoking cessation and shared decisions about affordable devices. Reading this guide does not certify spirometry performance, independent acute-care management or specialist prescribing; those require supervised clinical assessment.
Key Exam Pearls for NEET PG
Asthma combines variable respiratory symptoms with variable expiratory airflow limitation. A normal examination or spirometry result between episodes does not automatically exclude it; repeat testing during symptoms or use another validated demonstration of variability. Bronchodilator reversibility supports the diagnosis but is neither universally present nor unique to asthma. Atopy, nocturnal or early-morning symptoms and trigger variability are supportive. Clubbing, fixed focal signs, chronic purulent sputum, stridor or weight loss should redirect the differential.
Control asks about recent symptoms and activity; future risk includes previous severe attacks, excess reliever use, poor ICS exposure, low lung function, incorrect technique and smoking. Adults and adolescents should not be managed with SABA alone. ICS-containing therapy reduces severe attacks. MART uses a supported ICS-formoterol product for both maintenance and relief; it is not a class property of every ICS-LABA inhaler. Before step-up, check diagnosis, adherence, technique, exposures and comorbidities. Repeated oral steroid bursts are a marker of poor control and cumulative toxicity.
Life-threatening attack clues are exhaustion, altered consciousness, silent chest, cyanosis, hypotension, poor respiratory effort and worsening gas exchange. A normal or rising carbon dioxide in a tiring patient is ominous. Treat promptly and reassess serially; do not sedate. In children, preschool viral wheeze is not synonymous with lifelong asthma. In pregnancy, maintain control with appropriate inhaled treatment. Biologics target selected severe phenotypes after specialist work-up and do not replace basic diagnosis, adherence or technique correction.
Frequently Asked Questions
Can asthma be diagnosed when spirometry is normal between episodes?
Yes, but a compatible history alone should not end the evaluation when objective testing is feasible. Asthma is variable, so spirometry may be normal when the person is well. Repeat testing during symptoms, assess bronchodilator change, or use serial peak flow or specialist challenge testing as appropriate while reconsidering alternative diagnoses.
Why is a reliever inhaler alone no longer considered safe long-term asthma care?
A short-acting bronchodilator can relieve bronchoconstriction but does not treat airway inflammation. Reliance on it can mask worsening risk, and frequent use is associated with attacks. Adults and adolescents should receive an ICS-containing strategy selected for their age, device, availability and clinical circumstances, with technique and adherence checked.
Should inhaled corticosteroid treatment be stopped during pregnancy?
No, not simply because of pregnancy. Poorly controlled asthma and maternal hypoxaemia can harm both mother and fetus. Effective ICS-containing treatment is generally continued, exacerbations are treated promptly, and medicine choices are reviewed with respiratory and obstetric clinicians rather than reduced through fear or without supervision.
When should a person with asthma be assessed for biologic treatment?
Biologic assessment belongs in specialist severe-asthma care when asthma remains uncontrolled or attacks continue despite a confirmed diagnosis, optimized high-dose ICS-containing treatment, correct technique, good adherence and management of exposures and comorbidities. Phenotype, biomarkers, eligibility, safety, response measures, affordability and access must all be considered.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic